// App-Quantinova.ai

: PREVALENCE AND RISK FACTORS FOR THROMBOSIS IN ADULT ITP PATIENTS TREATED WITH TPO-RA

Researchers

Presenter

  • Maria L Lozano

Principal Investigators

  • Mara Perera

  • Isidro Jarque

  • Rosa Campos

  • Toms Jos Gonzlez

  • Gonzalo Carreo

  • Nuria Bermejo

  • Mara Fernanda Lpez

  • Aurora de Andrs

  • David Valcrcel

  • Felipe Casado

  • Mara Teresa lvarez

  • Mara Isabel Orts

  • Silvana Novelli

  • Jos Ramn Gonzlez

  • Estefana Bolaos

  • Elsa Lpez Ansoar

  • Elisa Orna

  • Vicente Vicente

Medical Centers

  • Hematology and Medical Oncology Deparment,Hospital General Universitario Morales Meseguer. University of Murcia. IMIB-Arrixaca. CIBERER,Murcia,Spain

  • Hospital Regional de Malaga, Malaga, Spain

  • Hospital Universitario Doctor Negrin, Las Palmas De Gran Canaria, Spain

  • Pediatric Oncology, Hospital Universitari i Politecnic La Fe, Valencia, Spain

  • Hosp Jerez de la Frontera, Jerez de la Frontera, Spain

  • Hospital Universitario de Burgos, Burgos, Spain

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Hospital San Pedro de Alcantara, Caceres, Spain

  • Hospital Universitario A Coruna, A Coruna, Spain

  • Complexo Hospitalario Universitario de Santiago, Santiago, Spain

  • Hospital Universitario del Mar, Barcelona, Spain

  • Hospital Virgen de la Salud, Toledo, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital de Sagunto,Sagunto,Spain

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

  • Hospital Universitario De Salamanca-IBSAL, Salamanca, Spain

  • Hospital Clinico Universitario San Carlos, Madrid, Spain

  • Hospital Alvaro Cunqueiro, Vigo, Spain

  • Hospital Universitari Germans Trias i Pujol, Badalona, Spain

  • Hospital Morales Meseguer, Murcia, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Eltrombopag

  • Romiplostim

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A